Drug news
FDA approves generic Bonviva (Roche)
The FDA has approved the first generic versions of Boniva (ibandronic acid), from Roche, a once-monthly product to treat or prevent Osteoporosis in women after menopause. The manufacturers that have gained FDA approval for generic 150 milligram tablets are Apotex, Orchid Healthcare, and Mylan. The once-monthly Bonviva branded 150 mg tablet was originally approved by the FDA in March 2005.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins